TY - JOUR
T1 - The Role of Non-Invasive Multimodality Imaging in Chronic Coronary Syndrome
T2 - Anatomical and Functional Pathways
AU - Bergamaschi, Luca
AU - Pavon, Anna Giulia
AU - Angeli, Francesco
AU - Tuttolomondo, Domenico
AU - Belmonte, Marta
AU - Armillotta, Matteo
AU - Sansonetti, Angelo
AU - Foà, Alberto
AU - Paolisso, Pasquale
AU - Baggiano, Andrea
AU - Mushtaq, Saima
AU - De Zan, Giulia
AU - Carriero, Serena
AU - Cramer, Maarten-Jan
AU - Teske, Arco J
AU - Broekhuizen, Lysette
AU - van der Bilt, Ivo
AU - Muscogiuri, Giuseppe
AU - Sironi, Sandro
AU - Leo, Laura Anna
AU - Gaibazzi, Nicola
AU - Lovato, Luigi
AU - Pontone, Gianluca
AU - Pizzi, Carmine
AU - Guglielmo, Marco
N1 - Publisher Copyright:
© 2023 by the authors.
PY - 2023/6/16
Y1 - 2023/6/16
N2 - Coronary artery disease (CAD) is one of the major causes of mortality and morbidity worldwide, with a high socioeconomic impact. Currently, various guidelines and recommendations have been published about chronic coronary syndromes (CCS). According to the recent European Society of Cardiology guidelines on chronic coronary syndrome, a multimodal imaging approach is strongly recommended in the evaluation of patients with suspected CAD. Today, in the current practice, non-invasive imaging methods can assess coronary anatomy through coronary computed tomography angiography (CCTA) and/or inducible myocardial ischemia through functional stress testing (stress echocardiography, cardiac magnetic resonance imaging, single photon emission computed tomography-SPECT, or positron emission tomography-PET). However, recent trials (ISCHEMIA and REVIVED) have cast doubt on the previous conception of the management of patients with CCS, and nowadays it is essential to understand the limitations and strengths of each imaging method and, specifically, when to choose a functional approach focused on the ischemia versus a coronary anatomy-based one. Finally, the concept of a pathophysiology-driven treatment of these patients emerged as an important goal of multimodal imaging, integrating 'anatomical' and 'functional' information. The present review aims to provide an overview of non-invasive imaging modalities for the comprehensive management of CCS patients.
AB - Coronary artery disease (CAD) is one of the major causes of mortality and morbidity worldwide, with a high socioeconomic impact. Currently, various guidelines and recommendations have been published about chronic coronary syndromes (CCS). According to the recent European Society of Cardiology guidelines on chronic coronary syndrome, a multimodal imaging approach is strongly recommended in the evaluation of patients with suspected CAD. Today, in the current practice, non-invasive imaging methods can assess coronary anatomy through coronary computed tomography angiography (CCTA) and/or inducible myocardial ischemia through functional stress testing (stress echocardiography, cardiac magnetic resonance imaging, single photon emission computed tomography-SPECT, or positron emission tomography-PET). However, recent trials (ISCHEMIA and REVIVED) have cast doubt on the previous conception of the management of patients with CCS, and nowadays it is essential to understand the limitations and strengths of each imaging method and, specifically, when to choose a functional approach focused on the ischemia versus a coronary anatomy-based one. Finally, the concept of a pathophysiology-driven treatment of these patients emerged as an important goal of multimodal imaging, integrating 'anatomical' and 'functional' information. The present review aims to provide an overview of non-invasive imaging modalities for the comprehensive management of CCS patients.
KW - CAD
KW - cardiac magnetic resonance
KW - chronic coronary syndrome
KW - coronarycomputed tomography angiography
KW - echocardiography
KW - ischemia
KW - nuclear medicine
UR - http://www.scopus.com/inward/record.url?scp=85163923767&partnerID=8YFLogxK
U2 - 10.3390/diagnostics13122083
DO - 10.3390/diagnostics13122083
M3 - Review article
C2 - 37370978
SN - 2075-4418
VL - 13
JO - Diagnostics (Basel, Switzerland)
JF - Diagnostics (Basel, Switzerland)
IS - 12
M1 - 2083
ER -